EUVIMEDEUVIMED entdecken
Crossref

Anemoside B4 alleviates pulmonary fibrosis by targeting the Keap1/Nrf2 axis to suppress NLRP3 inflammasome-mediated pyroptosis and epithelial-mesenchymal transition

Qianqian Wang, Jiaojiao Meng, You Li, Yuanyuan Han, Aohan Li, Yunzhong Luo, Yingying Zhao, Xili Zhang, Siyuan Wu, Xiaying Cui, Yingqing Chen

Phytomedicine · 2026-07 · 156 · 158223

DOI: 10.1016/j.phymed.2026.158223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-07. Verfasst von Qianqian Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Research Center, Dalian University, Dalian 116622, Liaoning Province, China; Chronic Disease Research Center, Medical College,…. Hauptthemen laut MEDLINE: Saponins, Pulmonary Fibrosis, Kelch-Like ECH-Associated Protein 1, NF-E2-Related Factor 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Dalian High-Level Talent Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary fibrosis (PF) is a progressive and fatal disease with limited therapies. Anemoside B4 (AB4), an oleanane-type pentacyclic triterpenoid saponin isolated from the roots of Pulsatilla chinensis (Bunge) Regel, exhibits anti-inflammatory and anti-apoptotic activities, yet its mechanisms of action in PF have yet to be elucidated. PURPOSE: This study aimed to define the protective effects of AB4 against PF, focusing on the Keap1/Nrf2 axis, NLRP3-mediated pyroptosis, and epithelial-mesenchymal transition (EMT). METHODS: A bleomycin (BLM)-induced PF model was established in wild-type and Nlrp3-/- mice. AB4's efficacy was evaluated through pulmonary function, histology, and biochemical assays. Bulk RNA-seq, scRNA-seq, molecular docking, Co-IP, CETSA, and nuclear-cytoplasmic fractionation were utilized to dissect mechanisms. Key pathways were validated with HO-1and NLRP3 inhibitors ZnPP and MCC950, respectively. RESULTS: AB4 ameliorated weight loss, improved lung function, and reduced collagen deposition in the BLM challenge. It directly bound Keap1, disrupting the Keap1-Nrf2 complex and promoting Nrf2 nuclear translocation, which upregulated HO-1 and attenuated oxidative stress. AB4 subsequently inhibited NLRP3 inflammasome activation and pyroptosis. Single-cell analysis confirmed suppression of EMT. AB4's anti-fibrotic effect depended on HO-1 activity and was phenocopied in Nlrp3-deficient mice. CONCLUSION: This study first identifies AB4 as a preventive, rather than therapeutic, agent against PF. AB4 targets Keap1 to activate Nrf2-driven antioxidant responses, inhibits NLRP3-dependent pyroptosis, and attenuates secretome-driven EMT. AB4 thus presents a novel, mechanism-based candidate for clinical translation, specifically for the prevention or early intervention of progressive PF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaponinsPulmonary FibrosisKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2AnimalsMiceMice, KnockoutMaleMice, Inbred C57BLInflammasomesNLR Family, Pyrin Domain-Containing 3 Protein

Stichwörter der Autor:innen

Anemoside B4Keap1/Nrf2 pathwayOxidative stressPulmonary fibrosisPyroptosis

Substanzen

anemoside B4SaponinsKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Nlrp3 protein, mouseNfe2l2 protein, mouseKeap1 protein, mouseInflammasomesNLR Family, Pyrin Domain-Containing 3 Protein

Autor:innen und Institutionen

  • Translational Medicine Research Center, Dalian University, Dalian 116622, Liaoning Province, China; Chronic Disease Research Center, Medical College, Dalian University, Dalian, 116622 Liaoning, China.
  • Translational Medicine Research Center, Dalian University, Dalian 116622, Liaoning Province, China.
  • Immunology Biology Key Laboratory, Yanbian University, Yanji 133002, China.
  • Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Translational Medicine Research Center, Dalian University, Dalian 116622, Liaoning Province, China; Chronic Disease Research Center, Medical College, Dalian University, Dalian, 116622 Liaoning, China. Electronic address…

Förderung

  • National Natural Science Foundation of China
  • Dalian High-Level Talent Innovation Program

Zitieren

APA

Wang, Q., Meng, J., Li, Y., Han, Y., Li, A., Luo, Y., Zhao, Y., Zhang, X., Wu, S., Cui, X., & Chen, Y. (2026). Anemoside B4 alleviates pulmonary fibrosis by targeting the Keap1/Nrf2 axis to suppress NLRP3 inflammasome-mediated pyroptosis and epithelial-mesenchymal transition. Phytomedicine, 156, 158223. https://doi.org/10.1016/j.phymed.2026.158223

Vancouver

Wang Q, Meng J, Li Y, Han Y, Li A, Luo Y, et al. Anemoside B4 alleviates pulmonary fibrosis by targeting the Keap1/Nrf2 axis to suppress NLRP3 inflammasome-mediated pyroptosis and epithelial-mesenchymal transition. Phytomedicine. 2026;156:158223. doi:10.1016/j.phymed.2026.158223

BibTeX
@article{Wang2026,
  author = {Wang, Qianqian and Meng, Jiaojiao and Li, You and Han, Yuanyuan and Li, Aohan and Luo, Yunzhong and Zhao, Yingying and Zhang, Xili and Wu, Siyuan and Cui, Xiaying and Chen, Yingqing},
  title = {Anemoside B4 alleviates pulmonary fibrosis by targeting the Keap1/Nrf2 axis to suppress NLRP3 inflammasome-mediated pyroptosis and epithelial-mesenchymal transition},
  journal = {Phytomedicine},
  year = {2026},
  volume = {156},
  pages = {158223},
  doi = {10.1016/j.phymed.2026.158223}
}
Kostenlos starten →